3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Interventions
Cyclophosphamide
24
fludarabine phosphate
18
Whole-Body Irradiation
17
fludarabine
16
Mycophenolic Acid
16
Tacrolimus
12
Peripheral Blood Stem Cell Transplantation
12
Busulfan
12
Melphalan
11
apixaban
10
Biopsy
7
Rivaroxaban
6
Granulocyte Colony-Stimulating Factor
6
Specimen Handling
5
Filgrastim
5
Cyclosporine
5
Azacitidine
5
thymoglobulin
4
X-Rays
4
Sirolimus
4
Rituximab
4
Injections
4
Enoxaparin
4
Decitabine
4
Bone Marrow Transplantation
4
Aspirin
4
Antilymphocyte Serum
4
venetoclax
3
pegylated granulocyte colony-stimulating factor
3
hetrombopag
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
N(4)-oleylcytosine arabinoside
×
Classical hematology
×
1 year
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled